J. Wood (1989)
Fecundity and natural fertility in humans.Oxford reviews of reproductive biology, 11
C. Ficicioglu, T. Kutlu, Elif Bağlam, Zeynep Bakacak (2006)
Early follicular antimüllerian hormone as an indicator of ovarian reserve.Fertility and sterility, 85 3
Christine Cook, Y. Siow, Susan Taylor, M. Fallat (2000)
Serum müllerian-inhibiting substance levels during normal menstrual cycles.Fertility and sterility, 73 4
S. Muttukrishna, H. Suharjono, H. Mcgarrigle, M. Sathanandan (2004)
Inhibin B and anti‐Mullerian hormone: markers of ovarian response in IVF/ICSI patients?BJOG: An International Journal of Obstetrics & Gynaecology, 111
T. Eldar‐Geva, A. Ben-chetrit, I. Spitz, R. Rabinowitz, E. Markowitz, T. Mimoni, M. Gal, E. Zylber-Haran, E. Margalioth (2005)
Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcomeHuman Reproduction, 20
A. Marca, S. Malmusi, S. Giulini, L. Tamaro, R. Orvieto, Paola Levratti, A. Volpe (2004)
Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation.Human reproduction, 19 12
F. Broekmans, J. Kwee, D. Hendriks, B. Mol, C. Lambalk (2006)
A systematic review of tests predicting ovarian reserve and IVF outcome.Human reproduction update, 12 6
C. Koning, T. Benjamins, P. Harms, Roy Homburg, J. Montfrans, Joerg Gromoll, Manuela Simoni, C. Lambalk (2006)
The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles.Human reproduction, 21 2
M. Gruijters, J. Visser, A. Durlinger, A. Themmen (2003)
Anti-Müllerian hormone and its role in ovarian functionMolecular and Cellular Endocrinology, 211
C. Boomsma, N. Macklon (2006)
What can the clinician do to improve implantation?Reproductive biomedicine online, 13 6
(1994)
rate of nongrowing and early-growing follicles in aging women
J. Smeenk, F. Sweep, G. Zielhuis, J. Kremer, C. Thomas, D. Braat (2007)
Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.Fertility and sterility, 87 1
G. Scheffer, F. Broekmans, L. Bancsi, J. Habbema, C. Looman, E. Velde (2002)
Quantitative transvaginal two‐ and three‐dimensional sonography of the ovaries: reproducibility of antral follicle countsUltrasound in Obstetrics and Gynecology, 20
Mary Lee, P. Donahoe, T. Hasegawa, B. Silverman, G. Crist, Sharon Best, Y. Hasegawa, R. Noto, D. Schoenfeld, D. Maclaughlin (1996)
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.The Journal of clinical endocrinology and metabolism, 81 2
S. Muttukrishna, H. Mcgarrigle, R. Wakim, I. Khadum, D. Ranieri, P. Serhal (2005)
Antral follicle count, anti‐mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?BJOG: An International Journal of Obstetrics & Gynaecology, 112
B. Littenberg, L. Moses (1993)
Estimating Diagnostic Accuracy from Multiple Conflicting ReportsMedical Decision Making, 13
A. Spira (1988)
The decline of fecundity with age.Maturitas, Suppl 1
W. Hehenkamp, C. Looman, A. Themmen, F. Jong, E. Velde, F. Broekmans (2006)
Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.The Journal of clinical endocrinology and metabolism, 91 10
A. Hazout, P. Bouchard, D. Seifer, P. Aussage, A. Junca, P. Cohen-Bacrie (2004)
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.Fertility and sterility, 82 5
A. Marca, S. Giulini, A. Tirelli, E. Bertucci, T. Marsella, S. Xella, A. Volpe (2007)
Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.Human reproduction, 22 3
D. Hendriks, J. Kwee, B. Mol, E. Velde, F. Broekmans (2007)
Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count.Fertility and sterility, 87 4
J. Peñarrubia, F. Fábregues, D. Manau, M. Creus, G. Casals, R. Casamitjana, F. Carmona, J. Vanrell, J. Balasch (2005)
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.Human reproduction, 20 4
H. Lashen, W. Ledger, A. López-Bernal, D. Barlow (1999)
Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?Human reproduction, 14 4
A. Midgette, T. Stukel, B. Littenberg (1993)
A Meta-analytic Method for Summarizing Diagnostic Test PerformancesMedical Decision Making, 13
E. Klinkert, F. Broekmans, C Looman, J. Habbema, E. Velde, E. Velde (2005)
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial.Human reproduction, 20 3
J. Kwee, M. Elting, R. Schats, P. Bezemer, C. Lambalk, J. Schoemaker (2003)
Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study.Human reproduction, 18 7
Cory Koning, C. Popp‐Snijders, F. Martens, C. Lambalk (2000)
Short Communications Falsely Elevated Follicle-Stimulating Hormone Levels in Women with Regular Menstrual Cycles due to Interference in Immunoradiometric AssayJournal of Assisted Reproduction and Genetics, 17
Thierry Pache, J. Wladimiroff, F. Jong, Wim Hop, Bart Fauser (1990)
Growth patterns of nondominant ovarian follicles during the normal menstrual cycle.Fertility and sterility, 54 4
D. Maclaughlin (1990)
An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.The Journal of clinical endocrinology and metabolism, 70 1
E. Klinkert, F. Broekmans, C. Looman, E. Velde (2004)
A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles.Fertility and sterility, 81 5
J. Disseldorp, Mjc Eijkemans, ER Klinkert, ER Velde, B. Fauser, F. Broekmans (2007)
Cumulative live birth rates following IVF in 41- to 43-year-old women presenting with favourable ovarian reserve characteristics.Reproductive biomedicine online, 14 4
B. Mol, T. Verhagen, D. Hendriks, J. Collins, A. Coomarasamy, B. Opmeer, F. Broekmans (2006)
Value of ovarian reserve testing before IVF: a clinical decision analysis.Human reproduction, 21 7
D. Hendriks, B. Mol, L. Bancsi, E. Velde, F. Broekmans (2005)
Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level.Fertility and sterility, 83 2
F. Broekmans, E. Knauff, E. Velde, N. Macklon, B. Fauser (2007)
Female reproductive ageing: current knowledge and future trendsTrends in Endocrinology & Metabolism, 18
(2008)
AMH in IVF outcome prediction
I. Rooij, E. Jong, F. Broekmans, C Looman, J. Habbema, E. Velde (2004)
High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment.Fertility and sterility, 81 6
MH Gaast, M. Eijkemans, JB Net, EJ Boer, CW Burger, F. Leeuwen, B. Fauser, N. Macklon (2006)
Optimum number of oocytes for a successful first IVF treatment cycle.Reproductive biomedicine online, 13 4
D. Seifer, D. Maclaughlin, Benjamin Christian, Bo Feng, R. Shelden (2002)
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.Fertility and sterility, 77 3
E. Velde, P. Pearson (2002)
The variability of female reproductive ageing.Human reproduction update, 8 2
T. Fréour, S. Mirallié, K. Bach-Ngohou, M. Denis, P. Barrière, D. Masson (2007)
Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART).Clinica chimica acta; international journal of clinical chemistry, 375 1-2
M. Mcilveen, J. Skull, William Ledger, William Ledger (2007)
Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.Human reproduction, 22 3
C. Weenen, J. Laven, A. Bergh, M. Cranfield, N. Groome, J. Visser, P. Kramer, B. Fauser, A. Themmen (2004)
Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.Molecular human reproduction, 10 2
H. Léridon (2006)
Demographic effects of the introduction of steroid contraception in developed countries.Human reproduction update, 12 5
B. Popovic-Todorovic, A. Loft, H.Ejdrup Bredkjæer, S. Bangsbøll, Ingrid Nielsen, A. Andersen (2003)
A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment.Human reproduction, 18 11
K. Hansen, Jamie Morris, A. Thyer, M. Soules (2003)
Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting.Fertility and sterility, 80 3
Lincoln Moses, David Shapiro, B. Littenberg (1993)
Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations.Statistics in medicine, 12 14
C. Lambalk, C. Koning (1998)
Interpretation of elevated FSH in the regular menstrual cycle.Maturitas, 30 2
Hudson (1990)
An immunoassay to detect human mullerian inhibiting substance in males and females during normal developmentJ.Clin Endocrinol Metab, 70
Annemarie Vet, J. Laven, F. Jong, A. Themmen, B. Fauser (2002)
Antimüllerian hormone serum levels: a putative marker for ovarian aging.Fertility and sterility, 77 2
A. Marca, Gaspare Stabile, A. Artenisio, A. Volpe, A. Volpe (2006)
Serum anti-Mullerian hormone throughout the human menstrual cycle.Human reproduction, 21 12
A. Templeton, J. Morris, William Parslow (1996)
Factors that affect outcome of in-vitro fertilisation treatmentThe Lancet, 348
T. Ebner, M. Sommergruber, M. Moser, O. Shebl, E. Schreier-Lechner, Gernot Tews (2006)
Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles.Human reproduction, 21 8
K. Tremellen, Michele Kolo, Alan Gilmore, Dharmawijaya Lekamge (2005)
Anti‐müllerian hormone as a marker of ovarian reserve *Australian and New Zealand Journal of Obstetrics and Gynaecology, 45
I.A.J. Rooij, F. Broekmans, E. Velde, B. Fauser, L. Bancsi, F. Jong, A. Themmen (2002)
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.Human reproduction, 17 12
B. Tarlatzis, L. Zepiridis, G. Grimbizis, J. Bontis (2003)
Clinical management of low ovarian response to stimulation for IVF: a systematic review.Human reproduction update, 9 1
A. Gougeon, René Ecochard, J. Thalabard (1994)
Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women.Biology of reproduction, 50 3
Gougeon (1994)
Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of nongrowing and early- growing follicles in aging womenBiol Reprod, 50
L. Hefler, C. Grimm, Eva-Katrin Bentz, A. Reinthaller, G. Heinze, C. Tempfer (2006)
A model for predicting age at menopause in white women.Fertility and sterility, 85 2
R. Fanchin, L. Schonäuer, C. Righini, N. Frydman, R. Frydman, J. Taieb (2003)
Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.Human reproduction, 18 2
Fertility and Sterility – Unpaywall
Published: Mar 6, 2008
Access the full text.
Sign up today, get DeepDyve free for 14 days.